Browse Title Index
Issue Title
Vol 14, Supp. A (2018) Długotrwała odpowiedź na terapię pembrolizumabem Abstract   PDF (Polish)
Karolina Łopacka-Szatan
Vol 7, Supp. E (2011) Długotrwała stabilizacja choroby u chorej na rozsianego raka piersi z nadmierną ekspresją receptora HER2, z obniżoną sprawnością ogólną po operacji neurochirurgicznej, leczonej lapatynibem z kapecytabiną Abstract   PDF (Polish)
Lubomir Bodnar
Vol 10, Supp. A (2014) Długotrwała terapia sunitynibem chorego na jasnokomórkowego raka nerki Details   PDF (Polish)
Małgorzata Foszczyńska-Kłoda
Vol 10, Supp. A (2014) Długotrwałe leczenie sunitynibem chorego na rozsianego jasnokomórkowego raka nerki z szybką progresją po leczeniu bewacyzumabem i interferonem Details   PDF (Polish)
Elżbieta Senkus
Vol 11, No 6 (2015) Early and late follow-up of patients with Hodgkin’s lymphoma. Recommendations of the Polish Lymphoma Research Group Abstract   PDF   HTML
Paweł Kurczab, Anna Czyż, Elżbieta Turska, Joanna Drozd-Sokołowska, Edyta Subocz, Agnieszka Szymczyk, Waldemar Tomczak, Jadwiga Hołojda, Wojciech Jurczak, Jan Walewski, Jan Maciej Zaucha
Vol 17, No 3 (2021) Early-stage gastric cancer presenting with tripe palm and acanthosis nigricans Abstract   PDF
Mehmet Zahid Kocak, Murat Araz, Mustafa Korkmaz, Aykut Demirkiran
Vol 9, No 2 (2013) Economic evaluation of anti-cancer therapies — specific approach and challenges of clinical outcomes assessment in oncology Abstract   PDF (Polish)
Rafał Zyśk, Maciej Niewada
Vol 15, No 6 (2019) Editorial Details   PDF
Piotr Rutkowski, Maciej Krzakowski
Vol 7, No 2 (2011) Edytorial Details   PDF (Polish)
Marek Pawlicki
Vol 7, No 5 (2011) Edytorial Details   PDF (Polish)
Marek Pawlicki
Vol 7, Supp. E (2011) Edytorial Abstract   PDF (Polish)
Aleksandra Łacko, Iwona Głogowska
Vol 10, Supp. A (2014) Efektywna 46-miesięczna terapia celowana pacjenta z zaawansowanym rakiem nerkowokomórkowym Details   PDF (Polish)
Artur Drobniak
Vol 18, No 3 (2022) Effect of ribociclib plus fulvestrant on overall survival in the treatment of advanced breast cancer — updated MONALEESA-3 results Abstract   PDF   HTML
Roman Dubiański
Vol 11, Supp. C (2015) Effective control of symptoms of advanced prostatic carcinoma — a case report of a patient treated with abiraterone acetate Abstract   PDF (Polish)
Łukasz Głogowski
Vol 11, No 2 (2015) Effective sequential chemoradiotherapy of a patient with locally advanced melanoma of the naso-ethmoidal massive Abstract   PDF (Polish)   HTML (Polish)
Kamila Patrycja Tabaka, Krystian Kidrycki, Marek Wojtukiewicz, Ewa Sierko
Vol 13, No 6 (2017) Effectiveness of nivolumab in an elderly patient with metastatic BRAF-negative melanoma originating from the anal region Abstract   PDF
Jacek Calik
Vol 19, No 5 (2023) Effects of the changes between preand post-treatment 18F-FDG PET-CT volumetric parameters on overall survival in pleural mesothelioma Abstract   PDF   HTML
Faris Tüzün, Senar Ebinç, Muhammet Ali Kaplan, İhsan Kaplan, Halil Kömek, Zeynep Oruç, Şadiye Kemal Tuzcu, Bekir Taşdemir
Vol 19, No 3 (2023) Efficacy of chemoimmunotherapy in a lung adenocarcinoma patient with mutations in the KRAS and STK11 Abstract   PDF   HTML
Natalia Krzyżanowska, Paweł Krawczyk, Izabela Chmielewska, Tomasz Jankowski, Kamila Wojas-Krawczyk, Janusz Milanowski
Vol 19, No 4 (2023) Efficacy of pemetrexed plus a platinum rechallenge in the treatment of pleural mesothelioma Abstract   PDF   HTML
Zuhat Urakçı, Senar Ebinç, Zeynep Oruç, Ziya Kalkan, Muhammet Ali Kaplan, Mehmet Küçüköner, Abdurrahman Işıkdoğan
Vol 13, No 4 (2017) Efficacy of regorafenib in gastrointestinal stromal tumors (GISTs) – a case report. Abstract   PDF   HTML
Iwona Ługowska, Anna Dawidowska, Anna Klimczak, Piotr Rutkowski
Vol 6, Supp. A (2010) Efficiency of liposomal doxorubicin in the treatment of advanced breast cancer after completed conventional doxorubicin cumulative dose Abstract   PDF (Polish)
Michał Tomala
Online first EGFR gene mutation and association with carcinoembryonic antigen status in non-small cell lung cancer — a cross-sectional study Abstract   PDF
Lam Van Ngo, Toan Khanh Nguyen, Hung Duc Tran, Uyen Tu Thi Nguyen, Hien Thu Thi Tran, Thanh Van Le
Vol 10, Supp. G (2014) EGFR mutated (exon 21) metastatic lung adenocarcinoma in female patient treated with erlotinib — case report Abstract   PDF (Polish)
Krzysztof Leśniewski-Kmak
Vol 19, No 5 (2023) EGFR mutation and ALK fusion-positive non-small cell lung cancer: a multicenter prospective cohort study in Nagano Prefecture, Japan Abstract   PDF   HTML
Takashi Kobayashi, Shintaro Kanda, Kazunari Tateishi, Nobutoshi Morozumi, Ryouhei Yamamoto, Fumiaki Yoshiike, Hideaki Takizawa, Munetaka Takada, Manabu Yamamoto, Kenichi Nishie, Takasuna Keiichiro, Toshihiko Agatsuma, Mineyuki Hama, Hozumi Tanaka, Akemi Matsuo, Akio Morikawa, Masayuki Hanaoka, Tomonobu Koizumi
Vol 10, No 4 (2014) EGFR tyrosine kinase inhibitors in the first-line or second-line treatment of patients with EGFR gene activating mutation Abstract   PDF (Polish)
Magdalena Knetki-Wróblewska, Adam Płużański, Maciej Krzakowski
326 - 350 of 1173 Items <<   <   9 10 11 12 13 14 15 16 17 18   >   >> 

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl